- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT07798986
Acupuncture for Generalized Anxiety Disorder
31 août 2026 mis à jour par: Second Affiliated Hospital, Zhejiang University, School of Medicine
Efficacy of Different Electroacupuncture Parameters for Generalized Anxiety Disorder: A Randomized Controlled Trial
Generalized anxiety disorder (GAD) is a common mental disorder characterized by persistent excessive worry, which seriously affects patients' quality of life.
Electroacupuncture (EA) has been widely used in the clinical treatment of anxiety disorders, but the optimal stimulation parameters remain unclear.
This study will adopt a randomized controlled trial (RCT) design to systematically compare the clinical efficacy of three different EA stimulation parameters (2 Hz continuous wave, 100 Hz continuous wave, and 2 Hz/100 Hz dense-disperse wave) in patients with GAD.
Multidimensional outcome assessment tools will be used to comprehensively evaluate the therapeutic effects of different stimulation modes.
The results of this study are expected to provide evidence-based reference for the selection of electroacupuncture parameters in the treatment of GAD, so as to optimize the clinical treatment regimen and improve the therapeutic effect.
Aperçu de l'étude
Statut
Pas encore de recrutement
Les conditions
Type d'étude
Interventionnel
Inscription (Estimé)
120
Phase
- N'est pas applicable
Contacts et emplacements
Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.
Coordonnées de l'étude
- Nom: Xiaoting Wu, Doctor
- Numéro de téléphone: +8618196671636
- E-mail: xiaotwu@163.com
Lieux d'étude
-
-
Zhejiang
-
Hangzhou, Zhejiang, Chine
- 2nd Affiliated Hospital, School of Medicine, Zhejiang University, China
-
-
Critères de participation
Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.
Critère d'éligibilité
Âges éligibles pour étudier
- Adulte
Accepte les volontaires sains
Non
La description
Inclusion Criteria:
Only those who meet the following four criteria simultaneously can be included in this study:
- Meet the diagnostic criteria for GAD;
- Between 18 and 60 years old;
- Conscious and able to communicate normally;
- Have good compliance, be willing to cooperate with the study, and sign the informed consent form.
Exclusion Criteria:
Exclude patients meeting any of the following criteria:
- Organic mental disorder, schizophrenia, bipolar disorder, mania/other psychoses, alcohol/drug addiction, current drug use disorder/lifetime drug abuse, post-stroke/postpartum anxiety;
- History of suicidal behavior or severe suicidal tendency;
- Pregnancy or breastfeeding;
- Mental retardation, unable to cooperate;
- Electroacupuncture contraindications: bleeding tendency, coagulation dysfunction, internal metal implants;
- Participation in other clinical trials within 1 month.
Plan d'étude
Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Traitement
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Tripler
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Comparateur factice: sham electroacupuncture group (SEA group)
In the SEA group, shallow punctures were made at the points 1 cm outward/radially from bilateral Neiguan (PC6), Shenmen (HT7), Taichong (LR3), Sanyinjiao (SP6), and Sishencong (EX-HN1) respectively, and then the power was cut off after connecting the electro - acupuncture device.Each treatment lasts 30 minutes, with 3 treatments per week for 4 consecutive weeks, totaling 12 treatments.
|
After connecting the electro - acupuncture device, the power was cut off for 30 minutes each time.Treatment was carried out 3 times a week for 4 consecutive weeks, a total of 12 times.
Needles with a specification of 0.25×25mm were selected.
Manual acupuncture is performed at the acupoints of Neiguan (PC6), Shenmen (HT7), Taichong (LR3), Sanyinjiao (SP6) and Sishencong (EX-HN1).
|
|
Expérimental: 2Hz continuous wave electroacupuncture group (2Hz EA group)
Needles are routinely inserted at bilateral Neiguan (PC6), Shenmen (HT7), Taichong (LR3), Sanyinjiao (SP6) and Sishencong (EX-HN1).
Electroacupuncture is applied to bilateral Shenmen-Neiguan pairs, with intensity adjusted to subject tolerance, and frequencies of 2Hz.
30 minutes per session, 3 sessions weekly for 4 consecutive weeks, 12 sessions total.
|
Needles with a specification of 0.25×25mm were selected.
Manual acupuncture is performed at the acupoints of Neiguan (PC6), Shenmen (HT7), Taichong (LR3), Sanyinjiao (SP6) and Sishencong (EX-HN1).
Electro-acupuncture device was connected to the bilateral Shenmen (HT7) and Neiguan (PC6) acupoints.
The intensity was set to the level that the subjects could tolerate, and the frequencies were 2Hz for 30 minutes each time.
Treatment was carried out 3 times a week for 4 consecutive weeks, a total of 12 times.
|
|
Expérimental: 100Hz continuous wave electroacupuncture group (100Hz EA group)
Needles are routinely inserted at bilateral Neiguan (PC6), Shenmen (HT7), Taichong (LR3), Sanyinjiao (SP6) and Sishencong (EX-HN1).
Electroacupuncture is applied to bilateral Shenmen-Neiguan pairs, with intensity adjusted to subject tolerance, and frequencies of 100Hz.
30 minutes per session, 3 sessions weekly for 4 consecutive weeks, 12 sessions total.
|
Needles with a specification of 0.25×25mm were selected.
Manual acupuncture is performed at the acupoints of Neiguan (PC6), Shenmen (HT7), Taichong (LR3), Sanyinjiao (SP6) and Sishencong (EX-HN1).
Electro-acupuncture device was connected to the bilateral Shenmen (HT7) and Neiguan (PC6) acupoints.
The intensity was set to the level that the subjects could tolerate, and the frequencies were 100Hz for 30 minutes each time.
Treatment was carried out 3 times a week for 4 consecutive weeks, a total of 12 times.
|
|
Expérimental: 2Hz/100Hz dense-disperse wave electroacupuncture group (2Hz/100Hz EA group)
Needles are routinely inserted at bilateral Neiguan (PC6), Shenmen (HT7), Taichong (LR3), Sanyinjiao (SP6) and Sishencong (EX-HN1).
Electroacupuncture is applied to bilateral Shenmen-Neiguan pairs, with intensity adjusted to subject tolerance, and frequencies of 100Hz.
30 minutes per session, 3 sessions weekly for 4 consecutive weeks, 12 sessions total.
|
Needles with a specification of 0.25×25mm were selected.
Manual acupuncture is performed at the acupoints of Neiguan (PC6), Shenmen (HT7), Taichong (LR3), Sanyinjiao (SP6) and Sishencong (EX-HN1).
Electro-acupuncture device was connected to the bilateral Shenmen (HT7) and Neiguan (PC6) acupoints.
The intensity was set to the level that the subjects could tolerate, and the frequencies were 2Hz/100Hz for 30 minutes each time.
Treatment was carried out 3 times a week for 4 consecutive weeks, a total of 12 times.
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
the score of Hamilton anxiety rating scale, HAMA
Délai: week 0, week 4, week 8 and week 16 after enrollment
|
This scale consists of 14 items.
Trained physicians or assessors conduct a semi-structured interview to rate the subject's recent anxiety symptoms.
The items cover two major dimensions: psychic anxiety (e.g., tension, fear) and somatic anxiety (e.g., muscle tension, cardiovascular symptoms).A higher score indicates more severe symptoms, with 7 set as the cut-off value.
|
week 0, week 4, week 8 and week 16 after enrollment
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
the score of Zung self-rating anxiety scale, SAS
Délai: week 0, week 4, week 8 and week 16 after enrollment
|
This rating scale contains 20 items, and subjects complete the self-assessment independently without external interference.
The standard score ranges from 25 to 100.
A higher SAS score indicates more severe symptoms, with 53 set as the cut-off value.
|
week 0, week 4, week 8 and week 16 after enrollment
|
|
the score of Pittsburgh sleep quality index, PSQI
Délai: week 0, week 4, week 8 and week 16 after enrollment
|
PSQI is commonly used to assess the sleep quality of participants over the past month.
The total score ranges from 0 to 21.
A higher PSQI score indicates poorer sleep quality, with a cut-off value of 7.
|
week 0, week 4, week 8 and week 16 after enrollment
|
|
the score of Short form-12 health survey, SF-12
Délai: week 0, week 4, week 8 and week 16 after enrollment
|
This scale consists of 12 items, which is used to evaluate the recent health status of subjects, covering dimensions including physical function, pain, vitality, and social function.
A higher score indicates better health status, and a standard score below 50 indicates that the health status is below the average level.
|
week 0, week 4, week 8 and week 16 after enrollment
|
Autres mesures de résultats
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Number of participants with treatment-related adverse events as assessed by CTCAE v4.0
Délai: From enrollment to the end of treatment at 4 weeks
|
Details of all adverse events will be recorded on the Case Report Form (CRF).
Number of participants with treatment-related adverse events as assessed by CTCAE v4.0 after the completion of the trial.
|
From enrollment to the end of treatment at 4 weeks
|
|
acupuncture compliance rate
Délai: 4 weeks after treatment
|
At the end of the acupuncture intervention (end of week 4), compliance will be evaluated with the formula: Compliance Rate = (actual treatment times/total treatment times) *100%.
|
4 weeks after treatment
|
|
the level of Heart Rate Variability
Délai: week 0 and week 6 after enrollment
|
After obtaining the consent of the subjects, the level of Heart Rate Variability data will be collected before and after the intervention to further explore the anti - anxiety mechanism of electroacupuncture.
|
week 0 and week 6 after enrollment
|
Collaborateurs et enquêteurs
C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.
Dates d'enregistrement des études
Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.
Dates principales de l'étude
Début de l'étude (Estimé)
1 septembre 2026
Achèvement primaire (Estimé)
30 octobre 2028
Achèvement de l'étude (Estimé)
31 décembre 2028
Dates d'inscription aux études
Première soumission
24 juin 2026
Première soumission répondant aux critères de contrôle qualité
31 août 2026
Première publication (Réel)
2 septembre 2026
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
2 septembre 2026
Dernière mise à jour soumise répondant aux critères de contrôle qualité
31 août 2026
Dernière vérification
1 juin 2026
Plus d'information
Termes liés à cette étude
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- MR-33-25-070485
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
INDÉCIS
Description du régime IPD
Regarding the scope of data sharing and the rules for usage authorization, the parties involved in the research cooperation are still in communication and negotiation, and no final decision has been made yet.
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Non
Étudie un produit d'appareil réglementé par la FDA américaine
Non
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .